BIOMARIN PHARMACEUTICAL INC Property, Plant and Equipment, Gross
BIOMARIN PHARMACEUTICAL INC (BMRN) had Property, Plant and Equipment, Gross of $2.10 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-06
- 2026-06-30: Property, Plant and Equipment, Gross $2.10B.
- 2026-03-31: Property, Plant and Equipment, Gross $2.05B.
- 2025-12-31: Property, Plant and Equipment, Gross $2.03B.
- 2025-09-30: Property, Plant and Equipment, Gross $1.99B.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $2.10B 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.05B 10-Q · filed 2026-05-05 |
| 2025-12-31 | $2.03B 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.99B 10-Q · filed 2025-10-28 |
| 2025-06-30 | $1.96B 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.94B 10-Q · filed 2025-05-02 |
| 2024-12-31 | $1.93B 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.91B 10-Q · filed 2024-10-31 |
| 2024-06-30 | $1.96B 10-Q · filed 2024-08-05 |
| 2024-03-31 | $1.95B 10-Q · filed 2024-04-26 |
| 2023-12-31 | $1.93B 10-K · filed 2025-02-24 |
| 2023-09-30 | $1.92B 10-Q · filed 2023-11-02 |
| 2023-06-30 | $1.90B 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.88B 10-Q · filed 2023-04-28 |
| 2022-12-31 | $1.88B 10-K · filed 2024-02-26 |
| 2022-09-30 | $1.83B 10-Q · filed 2022-10-28 |
| 2022-06-30 | $1.81B 10-Q · filed 2022-08-04 |
| 2022-03-31 | $1.78B 10-Q · filed 2022-04-29 |
| 2021-12-31 | $1.76B 10-K · filed 2023-02-27 |
| 2021-09-30 | $1.72B 10-Q · filed 2021-10-29 |
| 2021-06-30 | $1.70B 10-Q · filed 2021-07-30 |
| 2021-03-31 | $1.68B 10-Q · filed 2021-04-30 |
| 2020-12-31 | $1.67B 10-K · filed 2022-02-25 |
| 2020-09-30 | $1.63B 10-Q · filed 2020-11-06 |
| 2020-06-30 | $1.60B 10-Q · filed 2020-08-05 |
| 2020-03-31 | $1.58B 10-Q · filed 2020-05-01 |
| 2019-12-31 | $1.56B 10-K · filed 2021-02-26 |
| 2019-09-30 | $1.50B 10-Q/A · filed 2019-11-04 |
| 2019-06-30 | $1.48B 10-Q · filed 2019-08-02 |
| 2019-03-31 | $1.45B 10-Q · filed 2019-04-29 |
| 2018-12-31 | $1.42B 10-K · filed 2020-02-27 |
| 2018-09-30 | $1.39B 10-Q · filed 2018-10-26 |
| 2018-06-30 | $1.34B 10-Q · filed 2018-08-03 |
| 2018-03-31 | $1.32B 10-Q · filed 2018-04-27 |
| 2017-12-31 | $1.30B 10-K · filed 2019-02-28 |
| 2017-09-30 | $1.27B 10-Q · filed 2017-10-31 |
| 2017-06-30 | $1.22B 10-Q · filed 2017-08-02 |
| 2017-03-31 | $1.18B 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.14B 10-K · filed 2018-02-26 |
| 2016-09-30 | $1.06B 10-Q · filed 2016-11-03 |
| 2016-06-30 | $1.04B 10-Q · filed 2016-08-08 |
| 2016-03-31 | $1.01B 10-Q · filed 2016-05-02 |
| 2015-12-31 | $982.81M 10-K · filed 2017-02-27 |
| 2015-09-30 | $869.81M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $820.52M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $778.43M 10-Q · filed 2015-05-05 |
| 2014-12-31 | $752.40M 10-K · filed 2016-02-29 |
| 2014-09-30 | $702.63M 10-Q · filed 2014-10-28 |
| 2014-06-30 | $674.53M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $631.66M 10-Q · filed 2014-05-02 |
| 2013-12-31 | $504.36M 10-K · filed 2015-03-02 |
| 2013-09-30 | $462.11M 10-Q · filed 2013-10-28 |
| 2013-06-30 | $449.27M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $439.41M 10-Q · filed 2013-04-29 |
| 2012-12-31 | $433.60M 10-K · filed 2014-02-26 |
| 2012-09-30 | $414.34M 10-Q · filed 2012-10-29 |
| 2012-06-30 | $399.11M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $387.76M 10-Q · filed 2012-04-30 |
| 2011-12-31 | $384.72M 10-K · filed 2013-02-26 |
| 2011-09-30 | $374.05M 10-Q · filed 2011-10-31 |
| 2011-06-30 | $316.22M 10-Q · filed 2011-08-01 |
| 2010-12-31 | $306.94M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |